Audits of the prevention and treatment of corticosteroid-induced osteoporosis in outpatients with rheumatic diseases in the West Midlands

Author： Paskins Z Potter T Erb N Obrenovic K Rowe IF

Publisher： Royal College Of Physicians

ISSN： 1470-2118

Source： Clinical Medicine, Vol.6, Iss.2, 2006-03, pp. : 183-187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Corticosteroid-Induced Osteoporosis: Detection and Management

By Adachi J.D. Papaioannou A.

Drug Safety, Vol. 24, Iss. 8, 2001-01 ,pp. : 607-624

Adis International

Access to resources Recommend Favorite

Corticosteroid-induced osteoporosis: prescribing pattern varies in Canada

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 277, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Corticosteroid-Induced Adverse Events in Adults: Frequency, Screening and Prevention

By Fardet Laurence Kassar Abdulrhaman

Drug Safety, Vol. 30, Iss. 10, 2007-01 ,pp. : 861-881

Adis International

Access to resources Recommend Favorite

Use of Intralesional Poly-L-Lactic Acid in the Treatment of Corticosteroid-Induced Lipoatrophy

By Brodell David W. Marchese Johnson Sandra

Dermatologic Surgery, Vol. 40, Iss. 5, 2014-05 ,pp. : 597-599

Elsevier

Access to resources Recommend Favorite

The prevention and treatment of glucocorticoid-induced osteoporosis in clinical practice

By Walker-Bone Karen Wood Angela Hull Richard Ledingham Joanna M McCrae Fiona C Shaban Ragai Thomas Alastair Mackay Kirsten

Clinical Medicine, Vol. 4, Iss. 5, 2004-09 ,pp. : 431-436

Royal College Of Physicians

Access to resources Recommend Favorite